Roche cancer immunotherapy Tecentriq wins EU approval

ZURICH (Reuters) - Roche immunotherapy Tecentriq has won European Union approval for treating advanced lung and bladder cancer, the Swiss drugmaker said. The...

Novelion’s Aegerion resolves U.S. drug probes for $40 mln

BOSTON (Reuters) - Aegerion Pharmaceuticals Inc will plead guilty to two misdemeanors and pay $40.1 million to resolve investigations into its marketing and...

State funding changes in spotlight in Republican healthcare bill

WASHINGTON (Reuters) - Republican leaders sought to nail down the final votes needed to pass what U.S. Vice President Mike Pence on Thursday...

Alnylam’s RNAi drug succeeds in key study, shares soar

(Reuters) - Alnylam Pharmaceuticals Inc’s RNAi-based drug that targets a rare genetic disease met the main goal of a key study, in a...

US Military surgeons in Afghanistan treat civilian injuries

(Reuters Health) - At U.S. military facilities in Afghanistan, roughly half of the surgeries done for local civilians during more than a decade...
- Advertisement -

Latest article

Dolce & Gabbana play their trump card with queen of hearts collection

MILAN (Reuters) - Dolce & Gabbana, fashion’s most famous duo, played their trump card on Sunday with their spring summer 2018 collection themed...

Trump renews clash with U.S. sports world

SOMERSET, N.J. (Reuters) - President Donald Trump renewed his spat with the sports world on Sunday, again calling for National Football League owners...

Novelion’s Aegerion resolves U.S. drug probes for $40 million

BOSTON (Reuters) - Aegerion Pharmaceuticals Inc will plead guilty to two misdemeanors and pay $40.1 million to resolve investigations into its marketing and...